REPLIMUNE GROUP
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer. Replimune is developing novel, proprietary products intended to improve both the direct anti-tumor effects of selective virus replication and the potency of the immune response to the tumor antigens released. The Company’s Immulytic™ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral mediated immunogenic tumor cell kill... ing and the delivery of optimal combinations of immune activating proteins to the tumor and draining lymph nodes. The approach is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment. Replimune intends to progress these therapies rapidly through clinical trials and to combine with other immuno-oncology products with complementary mechanisms of action at an early stage.
REPLIMUNE GROUP
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2015-03-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.replimune.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
87 M USD
Technology used in webpage:
SPF Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA JsDelivr
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Series B - Replimune Group
Atlas Venture
Atlas Venture investment in Series B - Replimune Group
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Replimune Group
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Replimune Group
Omega Funds
Omega Funds investment in Series B - Replimune Group
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series B - Replimune Group
Leerink Partners
Leerink Partners investment in Series B - Replimune Group
Foresite Capital
Foresite Capital investment in Series B - Replimune Group
Forbion Capital Partners
Forbion Capital Partners investment in Series A - Replimune Group
Atlas Venture
Atlas Venture investment in Series A - Replimune Group
Key Employee Changes
| Date | New article |
|---|---|
| 2019-12-10 | Replimune Taps Ex-Merrimack Exec for Chief Financial Officer Post |
Official Site Inspections
http://www.replimune.com Semrush global rank: 2.4 M Semrush visits lastest month: 7.63 K
- Host name: server2.stellarhosting.com
- IP address: 104.161.44.18
- Location: Phoenix United States
- Latitude: 33.4413
- Longitude: -112.0421
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85034
